Pathology and FDG PET Correlation of Residual Lymph Nodes in Head and Neck Cancer After Radiation Treatment
- 1 June 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in American Journal of Clinical Oncology
- Vol. 30 (3), 264-270
- https://doi.org/10.1097/01.coc.0000257611.65290.aa
Abstract
Background: This study determines if postradiotherapy [18F]fluorodeoxyglucose positron emission tomography (FDG PET) can predict the pathology status of residual cervical lymph nodes in patients undergoing definitive radiotherapy for head and neck squamous cell carcinoma (HNSCC). Methods: Patients with stage N2 or higher HNSCC underwent PET and CT imaging after definitive radiotherapy. Patients with radiographically persistent lymphadenopathy underwent either neck dissection or fine needle aspiration (FNA) of the lymph nodes under ultrasound guidance. PET scan results were correlated with the pathologic findings of the residual lymphadenopathy. Results: Twenty-four hemi-necks in 23 patients with residual lymphadenopathy had neck dissection or FNA. The pathology correlated strongly with the post-RT FDG PET studies. All patients with a negative post-RT FDG PET and those with a maximum standardized uptake value (SUVmax) of less than 3.0 in the post-RT FDG PET were found to be free from residual viable tumor. Using a SUVmax of less than 3.0 as the criterion for a negative FDG PET study, the sensitivity, specificity, positive predictive value, and negative predictive value were 100%, 84.2%, 62.5%, and 100%, respectively. Conclusions: A negative post-RT FDG PET is very predictive of negative pathology in the residual lymph node after definitive radiotherapy for advanced HNSCC. A prospective clinical trial is warranted to determine if neck dissection can be withheld in these patients.Keywords
This publication has 24 references indexed in Scilit:
- Staging of Head and Neck Squamous Cell Cancer With Extended-Field FDG-PETJAMA Otolaryngology–Head & Neck Surgery, 2003
- Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Positron emission tomography in the evaluation of stage III and IV head and neck cancerHead & Neck, 2001
- The role of postradiotherapy neck dissection in supraglottic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2001
- The Role of Neck Dissection After Chemoradiotherapy for Oropharyngeal Cancer With Advanced Nodal DiseaseJAMA Otolaryngology–Head & Neck Surgery, 2001
- Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: For some or for all?Head & Neck, 1999
- Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck:Is Postradiotherapy Neck Dissection Necessary?Radiation Oncology Investigations, 1998
- Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapyHead & Neck, 1996
- Squamous cell carcinoma of the head and neck treated with radiation therapy: The role of neck dissection for clinically positive neck nodesInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynxThe American Journal of Surgery, 1972